Publicaciones en las que colabora con Mario De La Mata Fernández (37)

2024

  1. Advancements in Pharmacological Interventions and Novel Therapeutic Approaches for Amyotrophic Lateral Sclerosis

    Biomedicines, Vol. 12, Núm. 10

2019

  1. Atherosclerosis and coenzyme q10

    International Journal of Molecular Sciences, Vol. 20, Núm. 20

  2. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation

    Molecular Neurobiology, Vol. 56, Núm. 5, pp. 3638-3656

  3. Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 5, pp. 861-881

2018

  1. Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 12, pp. 3697-3713

  2. Removing heteroplasmic mitochondrial DNA mutations

    Advances in Health and Disease (Nova Science Publishers, Inc.), pp. 83-117

  3. Therapy with coenzyme Q10

    Coenzyme Q10: Uses, Health Effects and Role in Disease (Nova Science Publishers, Inc.), pp. 1-63

2017

  1. Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease

    Orphanet Journal of Rare Diseases, Vol. 12, Núm. 1, pp. 1-15

  2. Dynamic reorganization of the cytoskeleton during apoptosis: The two coffins hypothesis

    International Journal of Molecular Sciences, Vol. 18, Núm. 11

  3. Fluorinated Chaperone−β-Cyclodextrin Formulations for β-Glucocerebrosidase Activity Enhancement in Neuronopathic Gaucher Disease

    Journal of Medicinal Chemistry, Vol. 60, Núm. 5, pp. 1829-1842

  4. Two coffins and a funeral: early or late caspase activation determines two types of apoptosis induced by DNA damaging agents

    Apoptosis, Vol. 22, Núm. 3, pp. 421-436

2016

  1. AMPK Regulation of Cell Growth, Apoptosis, Autophagy, and Bioenergetics

    EXS, Vol. 107, pp. 45-71

  2. AMPK Regulation of Cell Growth, Apoptosis, Autophagy, and Bioenergetics (vol 107, pg 45, 2016)

    AMP-ACTIVATED PROTEIN KINASE

  3. AMPK as a target in rare diseases

    Current Drug Targets, Vol. 17, Núm. 8, pp. 921-931

  4. Amitriptyline induces mitophagy that precedes apoptosis in human HepG2 cells

    Genes and Cancer, Vol. 7, Núm. 7-8, pp. 260-277

  5. Targeting autophagy and mitophagy for mitochondrial diseases treatment

    Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 487-500

  6. The Role of Autophagy and Mitophagy in Mitochondrial Diseases

    Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging Volume 8- Human Diseases (Elsevier), pp. 155-172

  7. The connections among autophagy, inflammasome and mitochondria

    Current Drug Targets, Vol. 17, Núm. 16

2015

  1. Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 11, pp. 2535-2553

  2. Emerging roles of apoptotic microtubules during the execution phase of apoptosis

    Cytoskeleton, Vol. 72, Núm. 9, pp. 435-446